The emerging role of complement lectin pathway in trypanosomatids: Molecular bases in activation, genetic deficiencies, susceptibility to infection, and complement system-based therapeutics

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Evans Osses, Ingrid ^a   De Messias Reason, Iara ^b   Ramirez, Marcel I ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FICOLIN; LECTIN; MANNAN BINDING LECTIN; FCN3 PROTEIN, HUMAN; GLYCOPROTEIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNOSE BINDING LECTIN; MASP2 PROTEIN, HUMAN; MBL2 PROTEIN, HUMAN;

COMPLEMENT ACTIVATION; COMPLEMENT LECTIN PATHWAY; COMPLEMENT SYSTEM; GENETIC DISORDER; HOST RESISTANCE; HUMAN; IMMUNE EVASION; INFECTION CONTROL; INFECTION SENSITIVITY; INNATE IMMUNITY; KINETOPLASTIDA; NONHUMAN; REVIEW; BLOOD; DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; IMMUNOLOGY; MALARIA;

COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HAPLOTYPES; HUMANS; IMMUNE EVASION; LECTINS; MALARIA; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; TRYPANOSOMATINA;

EID: 84874838229     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/675898     Document Type: Review

References (126)

1. Garlatti V., Belloy N., Martin L., Lacroix M., Matsushita M., Endo Y., Fujita T., Fontecilla-Camps J. C., Arlaud G. J., Thielens N. M., Gaboriaud C., Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO Journal 2007 26 2 623 633 2-s2.0-33846486352 10.1038/sj.emboj.7601500 (Pubitemid 46160961)
2. Krarup A., Mitchell D. A., Sim R. B., Recognition of acetylated oligosaccharides by human L-ficolin. Immunology Letters 2008 118 2 152 156 2-s2.0-44649141897 10.1016/j.imlet.2008.03.014
3. Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H., Fujita T., Activation of the lectin complement pathway by H-ficolin (Hakata antigen). Journal of Immunology 2002 168 7 3502 3506 2-s2.0-0036533701 (Pubitemid 34250417)
4. Runza V. L., Schwaeble W., Männel D. N., Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 2008 213 3-4 297 306 2-s2.0-41649110643 10.1016/j.imbio.2007.10.009 (Pubitemid 351479859)
5. Vorup-Jensen T., Petersen S. V., Hansen A. G., Poulsen K., Schwaeble W., Sim R. B., Reid K. B. M., Davis S. J., Thiel S., Jensenius J. C., Distinct pathways of mannan-binding lectin (MBL)- and C1-complex auatoactivation revealed by reconstitution of MBL with recombinant MBL- associated serine protease-2. Journal of Immunology 2000 165 4 2093 2100 2-s2.0-0034663925 (Pubitemid 30643158)
6. Matsushita M., Endo Y., Fujita T., Cutting edge: complement-activating complex of ficolin and mannose- binding lectin-associated serine protease. Journal of Immunology 2000 164 5 2281 2284 2-s2.0-0034163330 (Pubitemid 30115453)
7. Stover C. M., Thiel S., Thelen M., Lynch N. J., Vorup-Jensen T., Jensenius J. C., Schwaeble W. J., Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. Journal of Immunology 1999 162 6 3481 3490 2-s2.0-0033559136 (Pubitemid 29313599)
8. Weis W. I., Drickamer K., Hendrickson W. A., Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992 360 6400 127 134 2-s2.0-0026464832 10.1038/360127a0
9. Wong M., Sim R. B., Comparison of the complement system protein complexes formed by Clq and MBL. Biochemical Society Transactions 1997 25 1 41 2-s2.0-0031057175
10. Quesenberry M. S., Drickamer K., Determination of the minimum carbohydrate-recognition domain in two C-type animal lectins. Glycobiology 1991 1 6 615 621 2-s2.0-0026355241
11. 2+-dependent carbohydrate-recognition domain of a rat mannose-binding protein. Analysis by random cassette mutagenesis. Journal of Biological Chemistry 1992 267 15 10831 10841 2-s2.0-0026672997
12. Kawai T., Kase T., Suzuki Y., Eda S., Sakamoto T., Ohtani K., Wakamiya N., Anti-influenza A virus activities of mannan-binding lectins and bovine conglutinin. Journal of Veterinary Medical Science 2007 69 2 221 224 2-s2.0-33847685132 10.1292/jvms.69.221 (Pubitemid 46364399)
13. Jack D. L., Jarvis G. A., Booth C. L., Turner M. W., Klein N. J., Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C. Journal of Infectious Diseases 2001 184 7 836 845 2-s2.0-0035479073 10.1086/323204 (Pubitemid 32884217)
14. Cestari I. D. S., Krarup A., Sim R. B., Inal J. M., Ramirez M. I., Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Molecular Immunology 2009 47 2-3 426 437 2-s2.0-70450223706 10.1016/j.molimm.2009.08.030
15. Holmberg V., Schuster F., Dietz E., Sagarriga Visconti J. C., Anemana S. D., Bienzle U., Mockenhaupt F. P., Mannose-binding lectin variant associated with severe malaria in young African children. Microbes and Infection 2008 10 4 342 348 2-s2.0-43049084430 10.1016/j.micinf.2007.12.008
16. Lu J., Le Y., Kon O. L., Chan J., Lee S. H., Biosynthesis of human ficolin, and Escherichia coli -binding protein, by monocytes: comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor. Immunology 1996 89 2 289 294 2-s2.0-0029821215 (Pubitemid 26340136)
17. Harumiya S., Takeda K., Sugiura T., Fukumoto Y., Tachikawa H., Miyazono K., Fujimoto D., Ichijo H., Characterization of ficolins as novel elastin-binding proteins and molecular cloning of human ficolin-1. Journal of Biochemistry 1996 120 4 745 751 2-s2.0-0029853337 (Pubitemid 26385412)
18. Endo Y., Sato Y., Matsushita M., Fujita T., Cloning and characterization of the human lectin P35 gene and its related gene. Genomics 1996 36 3 515 521 2-s2.0-0030587494 10.1006/geno.1996.0497 (Pubitemid 26321974)
19. Matsushita M., Endo Y., Taira S., Sato Y., Fujita T., Ichikawa N., Nakata M., Mizuochi T., A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. Journal of Biological Chemistry 1996 271 5 2448 2454 2-s2.0-0030068057 10.1074/jbc.271.5.2448 (Pubitemid 26047848)
20. Le Y., Lee S. H., Kon O. L., Lu J., Human L-ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain. FEBS Letters 1998 425 2 367 370 2-s2.0-18344409247 10.1016/S0014- 5793(98)00267-1 (Pubitemid 28178923)
21. Wittenborn T., Thiel S., Jensen L., Nielsen H. J., Jensenius J. C., Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. Journal of Innate Immunity 2010 2 2 167 180 2-s2.0-77953402526 10.1159/000218324
22. Hummelshoj T., Thielens N. M., Madsen H. O., Arlaud G. J., Sim R. B., Garred P., Molecular organization of human Ficolin-2. Molecular Immunology 2007 44 4 401 411 2-s2.0-33748134380 10.1016/j.molimm.2006.02.023 (Pubitemid 44308353)
23. Ohashi T., Erickson H. P., The disulfide bonding pattern in ficolin multimers. Journal of Biological Chemistry 2004 279 8 6534 6539 2-s2.0-1342325430 10.1074/jbc.M310555200 (Pubitemid 38248788)
24. Tanio M., Kondo S., Sugio S., Kohno T., Trivalent recognition unit of innate immunity system: crystal structure of trimeric human M-ficolin fibrinogen-like domain. Journal of Biological Chemistry 2007 282 6 3889 3895 2-s2.0-33947509607 10.1074/jbc.M608627200 (Pubitemid 47084438)
25. Liu Y., Endo Y., Iwaki D., Nakata M., Matsushita M., Wada I., Inoue K., Munakata M., Fujita T., Human M-ficolin is a secretory protein that activates the lectin complement pathway. Journal of Immunology 2005 175 5 3150 3156 2-s2.0-23844486704 (Pubitemid 41170536)
26. Krarup A., Thiel S., Hansen A., Fujita T., Jensenius J. C., L-ficolin is a pattern recognition molecule specific for acetyl groups. Journal of Biological Chemistry 2004 279 46 47513 47519 2-s2.0-9144249121 10.1074/jbc.M407161200 (Pubitemid 39540895)
27. Ohashi T., Erickson H. P., Oligomeric structure and tissue distribution of ficolins from mouse, pig and human. Archives of Biochemistry and Biophysics 1998 360 2 223 232 2-s2.0-0032534784 10.1006/abbi.1998.0957 (Pubitemid 29001751)
28. Lynch N. J., Roscher S., Hartung T., Morath S., Matsushita M., Maennel D. N., Kuraya M., Fujita T., Schwaeble W. J., L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. Journal of Immunology 2004 172 2 1198 1202 2-s2.0-1642495736 (Pubitemid 38113782)
29. Nahid A. M., Sugii S., Binding of porcine ficolin- α to lipopolysaccharides from Gram-negative bacteria and lipoteichoic acids from Gram-positive bacteria. Developmental and Comparative Immunology 2006 30 3 335 343 2-s2.0-27644539147 10.1016/j.dci.2005.04.002 (Pubitemid 41571273)
30. Liu J., Ali M. A. M., Shi Y., Zhao Y., Luo F., Yu J., Xiang T., Tang J., Li D., Hu Q., Ho W., Zhang X., Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cellular and Molecular Immunology 2009 6 4 235 244 2-s2.0-69949118734 10.1038/cmi.2009.32
31. Ma Y. G., Cho M. Y., Zhao M., Park J. W., Matsushita M., Fujita T., Lee B. L., Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. Journal of Biological Chemistry 2004 279 24 25307 25312 2-s2.0-2942593797 10.1074/jbc.M400701200 (Pubitemid 38756784)
32. Kuraya M., Matsushita M., Endo Y., Thiel S., Fujita T., Expression of H-ficolin/Hakata antigen, mannose-binding lectin-associated serine protease (MASP)-1 and MASP-3 by human glioma cell line T98G. International Immunology 2003 15 1 109 117 2-s2.0-0037256549 10.1093/intimm/dxg008 (Pubitemid 36163773)
33. Ohashi T., Erickson H. P., Two oligomeric forms of plasma ficolin have differential lectin activity. Journal of Biological Chemistry 1997 272 22 14220 14226 2-s2.0-0031009906 10.1074/jbc.272.22.14220 (Pubitemid 27232833)
34. Gout E., Garlatti V., Smith D. F., Lacroix M., Dumestre-Pérard C., Lunardi T., Martin L., Cesbron J. Y., Arlaud G. J., Gaboriaud C., Thielens N. M., Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. Journal of Biological Chemistry 2010 285 9 6612 6622 2-s2.0-77949878087 10.1074/jbc.M109.065854
35. Swierzko A., Lukasiewicz J., Cedzynski M., MacIejewska A., Jachymek W., Niedziela T., Matsushita M., Lugowski C., New functional ligands for ficolin-3 among lipopolysaccharides of Hafnia alvei. Glycobiology 2012 22 2 267 280 10.1093/glycob/cwr119
36. Teh C., Le Y., Lee S. H., Lu J., M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli. Immunology 2000 101 2 225 232 2-s2.0-0033781775 10.1046/j.1365-2567.2000.00099.x
37. Honoré C., Rørvig S., Munthe-Fog L., Hummelshøj T., Madsen H. O., Borregaard N., Garred P., The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Molecular Immunology 2008 45 10 2782 2789 2-s2.0-41849097352 10.1016/j.molimm.2008.02.005
38. Garlatti V., Martin L., Gout E., Reiser J. B., Fujita T., Arlaud G. J., Thielens N. M., Gaboriaud C., Structural basis for innate immune sensing by M-ficolin and its control by a pH-dependent conformational switch. Journal of Biological Chemistry 2007 282 49 35814 35820 2-s2.0-37249053731 10.1074/jbc.M705741200 (Pubitemid 350277106)
39. Frederiksen P. D., Thiel S., Larsen C. B., Jensenius J. C., M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scandinavian Journal of Immunology 2005 62 5 462 473 2-s2.0-28344454827 10.1111/j.1365-3083.2005.01685.x (Pubitemid 41719322)
40. Tanio M., Wakamatsu K., Kohno T., Binding site of C-reactive protein on M-ficolin. Molecular Immunology 2009 47 2-3 215 221 2-s2.0-70450223687 10.1016/j.molimm.2009.09.032
41. Kjaer T. R., Hansen A. G., Sørensen U. B. S., Nielsen O., Thiel S., Jensenius J. C., Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association. Journal of Leukocyte Biology 2011 90 3 425 437 10.1189/jlb.0411201
42. Feinberg H., Uitdehaag J. C. M., Davies J. M., Wallis R., Drickamer K., Weis W. I., Crystal structure of the CUB1-EGF-CUB2 region of mannose-binding protein associated serine protease-2. EMBO Journal 2003 22 10 2348 2359 2-s2.0-0037904914 10.1093/emboj/cdg236 (Pubitemid 36604974)
43. Rossi V., Bally I., Thielens N. M., Esser A. F., Arlaud G. J., Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate. Journal of Biological Chemistry 1998 273 2 1232 1239 2-s2.0-0031964708 10.1074/jbc.273.2.1232 (Pubitemid 28049226)
44. Wallis R., Dodd R. B., Interaction of mannose-binding protein with associated serine proteases. Effects of naturally occurring mutations. Journal of Biological Chemistry 2000 275 40 30962 30969 2-s2.0-0034613383
45. Thiel S., Vorup-Jensen T., Stover C. M., Schwaeble W., Laursen S. B., Poulsen K., Willis A. C., Eggleton P., Hansen S., Holmskov U., Reid K. B. M., Jensenius J. C., A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997 386 6624 506 510 2-s2.0-0030950185 10.1038/386506a0 (Pubitemid 27164078)
46. Presanis J. S., Hajela K., Ambrus G., Gál P., Sim R. B., Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Molecular Immunology 2004 40 13 921 929 2-s2.0-0347915527 10.1016/j.molimm.2003. 10.013 (Pubitemid 38077036)
47. Ambrus G., Gál P., Kojima M., Szilágyi K., Balczer J., Antal J., Gráf L., Laich A., Moffatt B. E., Schwaeble W., Sim R. B., Závodszky P., Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. Journal of Immunology 2003 170 3 1374 1382 2-s2.0-0037310722 (Pubitemid 36139504)
48. Takahashi M., Iwaki D., Kanno K., Ishida Y., Xiong J., Matsushita M., Endo Y., Miura S., Ishii N., Sugamura K., Fujita T., Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. Journal of Immunology 2008 180 9 6132 6138 2-s2.0-44449099767
49. Skjoedt M. O., Hummelshoj T., Palarasah Y., Honore C., Koch C., Skjodt K., Garred P., A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. Journal of Biological Chemistry 2010 285 11 8234 8243 2-s2.0-77950909532 10.1074/jbc.M109.065805
50. Lambris J. D., Ricklin D., Geisbrecht B. V., Complement evasion by human pathogens. Nature Reviews Microbiology 2008 6 2 132 142 2-s2.0-38349048514 10.1038/nrmicro1824
51. Ambrosio A. R., De Messias-Reason I. J. T., Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism. Parasite Immunology 2005 27 9 333 340 2-s2.0-25444442321 10.1111/j.1365-3024.2005.00782.x (Pubitemid 41360828)
52. Evans-Osses I., Ansa-Addo E. A., Inal J. M., Ramirez M. I., Involvement of lectin pathway activation in the complement killing of Giardia intestinalis. Biochemical and Biophysical Research Communications 2010 395 3 382 386 2-s2.0-77951879743 10.1016/j.bbrc.2010.04.025
53. Green P. J., Feizi T., Stoll M. S., Thiel S., Prescott A., McConville M. J., Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein. Molecular and Biochemical Parasitology 1994 66 2 319 328 2-s2.0-0028121975 10.1016/0166-6851(94)90158-9 (Pubitemid 24272078)
54. Cestari I., Ramirez M. I., Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells. PloS One 2010 5 3 2-s2.0-79952118301 e9721
55. Yoshida N., Araguth M. F., Trypanolytic activity and antibodies to metacyclic trypomastigotes of Trypanosoma cruzi in non-Chagasic human sera. Parasite Immunology 1987 9 3 389 393 2-s2.0-0023240026 (Pubitemid 17074204)
56. Almeida I. C., Ferguson M. A. J., Schenkman S., Travassos L. R., Lytic anti- α -galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl- phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochemical Journal 1994 304 3 793 802 2-s2.0-0028670563
57. Almeida I. C., Milani S. R., Gorin P. A. J., Travassos L. R., Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti- α -galactosyl antibodies. Journal of Immunology 1991 146 7 2394 2400 2-s2.0-0025803681
58. Arnold J. N., Wormald M. R., Suter D. M., Radcliffe C. M., Harvey D. J., Dwek R. A., Rudd P. M., Sim R. B., Human serum IgM glycosylation: identification of glycoforms that can bind to Mannan-binding lectin. Journal of Biological Chemistry 2005 280 32 29080 29087 2-s2.0-23844468114 10.1074/jbc.M504528200 (Pubitemid 41161358)
59. Malhotra R., Wormald M. R., Rudd P. M., Fischer P. B., Dwek R. A., Sim R. B., Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Medicine 1995 1 3 237 243 2-s2.0-0028962403
60. Roos A., Bouwman L. H., Van Gijlswijk-Janssen D. J., Faber-Krol M. C., Stahl G. L., Daha M. R., Human IgA activates the complement system via the Mannan-Binding lectin pathway. Journal of Immunology 2001 167 5 2861 2868 2-s2.0-0035451107 (Pubitemid 32768920)
61. Cestari I. D. S., Evans-Osses I., Freitas J. C., Inal J. M., Ramirez M. I., Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi. Journal of Infectious Diseases 2008 198 9 1276 1283 2-s2.0-54249162286 10.1086/592167
62. Domínguez M., Moreno I., López-Trascasa M., Toraño A., Complement interaction with trypanosomatid promastigotes in normal human serum. Journal of Experimental Medicine 2002 195 4 451 459 2-s2.0-0037128162 10.1084/jem.20011319 (Pubitemid 34461298)
63. Joiner K., Sher A., Gaither T., Hammer C., Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. Proceedings of the National Academy of Sciences of the United States of America 1986 83 17 6593 6597 2-s2.0-0022977997 (Pubitemid 17174781)
64. Moreno I., Molina R., Toraño A., Laurin E., García E., Domínguez M., Comparative real-time kinetic analysis of human complement killing of Leishmania infantum promastigotes derived from axenic culture or from Phlebotomus perniciosus. Microbes and Infection 2007 9 14-15 1574 1580 2-s2.0-36749048148 10.1016/j.micinf.2007.09.009 (Pubitemid 350217088)
65. Stoermer K. A., Morrison T. E., Complement and viral pathogenesis. Virology 2011 411 2 362 373 2-s2.0-79952073504 10.1016/j.virol.2010.12.045
66. Cestari I., Ansa-Addo E., Deolindo P., Inal J. M., Ramirez M. I., Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. Journal of Immunology 2012 188 4 1942 1952 10.4049/jimmunol.1102053
67. Norris K. A., Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infection and Immunity 1998 66 6 2460 2465 2-s2.0-0031839851 (Pubitemid 28261739)
68. Norris K. A., Harth G., So M., Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies. Infection and Immunity 1989 57 8 2372 2377 2-s2.0-0024324834 (Pubitemid 19183845)
69. Ferreira V., Molina M. C., Valck C., Rojas Á., Aguilar L., Ramírez G., Schwaeble W., Ferreira A., Role of calreticulin from parasites in its interaction with vertebrate hosts. Molecular Immunology 2004 40 17 1279 1291 2-s2.0-1142285366 10.1016/j.molimm.2003.11.018 (Pubitemid 38210266)
70. Ferreira V., Valck C., Sánchez G., Gingras A., Tzima S., Molina M. C., Sim R., Schwaeble W., Ferreira A., The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. Journal of Immunology 2004 172 5 3042 3050 2-s2.0-1342303386 (Pubitemid 38263693)
71. Ramírez G., Valck C., Molina M. C., Ribeiro C. H., López N., Sánchez G., Ferreira V. P., Billetta R., Aguilar L., Maldonado I., Cattán P., Schwaeble W., Ferreira A., Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Immunobiology 2011 216 1-2 265 273 2-s2.0-78649498983 10.1016/j.imbio.2010.04.001
72. Valck C., Ramírez G., López N., Ribeiro C. H., Maldonado I., Sánchez G., Ferreira V. P., Schwaeble W., Ferreira A., Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Molecular Immunology 2010 47 7-8 1516 1521 2-s2.0-77950610010 10.1016/j.molimm.2010.01.019
73. Tambourgi D. V., Kipnis T. L., Da Silva W. D., Joiner K. A., Sher A., Heath S., Hall B. F., Ogden G. B., A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. Infection and Immunity 1993 61 9 3656 3663 2-s2.0-0027198268 (Pubitemid 23260034)
74. Fischer E., Ouaissi M. A., Velge P., Cornette J., Kazatchkine M. D., Gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway. Immunology 1988 65 2 299 303 2-s2.0-0023810857
75. Russell D. G., The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes. European Journal of Biochemistry 1987 164 1 213 221 2-s2.0-0023146963 (Pubitemid 17053686)
76. Brittingham A., Morrison C. J., McMaster W. R., McGwire B. S., Chang K. P., Mosser D. M., Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. Journal of Immunology 1995 155 6 3102 3111 2-s2.0-0029046678
77. Späth G. F., Epstein L., Leader B., Singer S. M., Avila H. A., Turco S. J., Beverley S. M., Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proceedings of the National Academy of Sciences of the United States of America 2000 97 16 9258 9263 2-s2.0-0034255342 10.1073/pnas.160257897 (Pubitemid 30626706)
78. Puentes S. M., Da Silva R. P., Sacks D. L., Hammer C. H., Joiner K. A., Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. Journal of Immunology 1990 145 12 4311 4316 2-s2.0-0025649097
79. Russo D. C. W., Williams D. J. L., Grab D. J., Mechanisms for the elimination of potentially lytic complement-fixing variable surface glycoprotein antibody-complexes in Trypanosoma brucei. Parasitology Research 1994 80 6 487 492 2-s2.0-0028120474 (Pubitemid 24261786)
80. Engstler M., Pfohl T., Herminghaus S., Boshart M., Wiegertjes G., Heddergott N., Overath P., Hydrodynamic flow-mediated protein sorting on the cell surface of Trypanosomes. Cell 2007 131 3 505 515 2-s2.0-35548966701 10.1016/j.cell.2007.08.046 (Pubitemid 350007695)
81. Rudenko G., African trypanosomes: the genome and adaptations for immune evasion. Essays in Biochemistry 2011 51 47 62
82. Deng J., Gold D., LoVerde P. T., Fishelson Z., Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin. Infection and Immunity 2003 71 11 6402 6410 2-s2.0-0242286553 10.1128/IAI.71.11.6402-6410. 2003 (Pubitemid 37337699)
83. Deng J., Gold D., LoVerde P. T., Fishelson Z., Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni. International Journal for Parasitology 2007 37 1 67 75 2-s2.0-33845679502 10.1016/j.ijpara.2006.09.011 (Pubitemid 44958563)
84. Inal J. M., Sim R. B., A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2. FEBS Letters 2000 470 2 131 134 2-s2.0-0034708410 10.1016/S0014-5793(00)01304-1 (Pubitemid 30151083)
85. Inal J. M., Schistosoma TOR (trispanning orphan receptor), a novel, antigenic surface receptor of the blood-dwelling, Schistosoma parasite. Biochimica et Biophysica Acta 1999 1445 3 283 298 2-s2.0-0033538308 10.1016/S0167-4781(99)00051-2 (Pubitemid 29298035)
86. Inal J. M., Schifferli J. A., Complement C2 receptor inhibitor trispanning and the β -chain of C4 share a binding site for complement C2. Journal of Immunology 2002 168 10 5213 5221 2-s2.0-0037093849 (Pubitemid 34495989)
87. Horta M. F. M., Ramalho-Pinto F. J., Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro. Journal of Experimental Medicine 1991 174 6 1399 1406
88. Frevert U., Schenkman S., Nussenzweig V., Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi. Infection and Immunity 1992 60 6 2349 2360 2-s2.0-0026693330
89. Luty A. J. F., Kun J. F. J., Kremsner P. G., Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. Journal of Infectious Diseases 1998 178 4 1221 1224 2-s2.0-0031684761 (Pubitemid 28452230)
90. Boldt A. B. W., Luty A., Grobusch M. P., Dietz K., Dzeing A., Kombila M., Kremsner P. G., Kun J. F. J., Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes and Immunity 2006 7 5 393 400 2-s2.0-33746337908 10.1038/sj.gene.6364312 (Pubitemid 44111644)
91. Mombo L. E., Lu C. Y., Ossari S., Bedjabaga I., Sica L., Krishnamoorthy R., Lapoumeroulie C., Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections. Genes and Immunity 2003 4 5 362 367 2-s2.0-1542392739 10.1038/sj.gene.6363979 (Pubitemid 38961144)
92. Garred P., Larsen F., Madsen H. O., Koch C., Mannose-binding lectin deficiency-revisited. Molecular Immunology 2003 40 2-4 73 84 2-s2.0-0042565848 10.1016/S0161-5890(03)00104-4 (Pubitemid 36959818)
93. De Miranda Santos I. K. F., Costa C. H. N., Krieger H., Feitosa M. F., Zurakowski D., Fardin B., Gomes R. B. B., Weiner D. L., Harn D. A., Ezekowitz R. A. B., Epstein J. E., Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infection and Immunity 2001 69 8 5212 5215 2-s2.0-0034923240 10.1128/IAI.69.8.5212-5215.2001 (Pubitemid 32674515)
94. Alonso D. P., Ferreira A. F. B., Ribolla P. E. M., Santos I. K. F. D. M., Pires E Cruz M. D. S., De Carvalho F. A., Abatepaulo A. R. R., Costa D. L., Werneck G. L., Farias T. J. C., Soares M. J. S., Costa C. H. N., Genotypes of the mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications. Journal of Infectious Diseases 2007 195 8 1212 1217 2-s2.0-34047223686 10.1086/512683 (Pubitemid 46543455)
95. Asgharzadeh M., Mazloumi A., Kafil H. S., Ghazanchaei A., Mannose-binding lectin gene and promoter polymorphism in visceral leishmaniasis caused by Leishmania infantum. Pakistan Journal of Biological Sciences 2007 10 11 1850 1854 2-s2.0-34247226084 (Pubitemid 46607936)
96. Luz P. R., Miyazaki M. I., Neto N. C., Nisihara R. M., Messias-Reason I. J., High levels of mannose-binding lectin are associated with the risk of severe cardiomyopathy in chronic Chagas Disease. International Journal of Cardiology 2010 143 3 448 450 2-s2.0-77956615816 10.1016/j.ijcard.2009.09.467
97. Boldt A. B. W., Luz P. R., Messias-Reason I. J. T., MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clinical Immunology 2011 140 1 63 70 2-s2.0-79958766754 10.1016/j.clim.2011.03.008
98. Sallenbach S., Thiel S., Aebi C., Otth M., Bigler S., Jensenius J. C., Schlapbach L. J., Ammann R. A., Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatric Allergy and Immunology 2011 22 4 424 430 2-s2.0-79955508081 10.1111/j.1399-3038.2010.01104.x
99. Munthe-Fog L., Hummelshøj T., Honoré C., Madsen H. O., Permin H., Garred P., Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. New England Journal of Medicine 2009 360 25 2637 2644 2-s2.0-67449161588 10.1056/NEJMoa0900381
100. Schlapbach L. J., Thiel S., Kessler U., Ammann R. A., Aebi C., Jensenius J. C., Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut 2011 60 10 1438 1439 10.1136/gut.2010.226027
101. Schlapbach L. J., Mattmann M., Thiel S., Boillat C., Otth M., Nelle M., Wagner B., Jensenius J. C., Aebi C., Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clinical Infectious Diseases 2010 51 2 153 162 2-s2.0-77954804740 10.1086/653531
102. Ouf E. A., Ojurongbe O., Akindele A. A., Sina-Agbaje O. R., Van Tong H., Adeyeba A. O., Kremsner P. G., Kun J. F., Velavan T., Ficolin-2 levels and FCN2 genetic polymorphisms as a susceptibility factor in schistosomiasis. The Journal of Infectious Diseases 2012 206 4 562 570 10.1093/infdis/jis396
103. Assaf A., van Hoang T., Faik I., Aebischer T., Kremsner P. G., Kun J. F. J., Velavan T. P., Genetic evidence of functional ficolin-2 haplotype as susceptibility factor in cutaneous leishmaniasis. PLoS ONE 2012 7 3 e34113 10.1371/journal.pone.0034113
104. Ruskamp J. M., Hoekstra M. O., Postma D. S., Kerkhof M., Bottema R. W., Koppelman G. H., Rovers M. M., Wijga A. H., De Jongste J. C., Brunekreef B., Sanders E. A. M., Exploring the role of polymorphisms in ficolin genes in respiratory tract infections in children. Clinical and Experimental Immunology 2009 155 3 433 440 2-s2.0-59249093489 10.1111/j.1365-2249.2008.03844.x
105. Kilpatrick D. C., Chalmers J. D., MacDonald S. L., Murray M., Mohammed A., Hart S. P., Matsushita M., Hill A., Stable bronchiectasis is associated with low serum L-ficolin concentrations. Clinical Respiratory Journal 2009 3 1 29 33 2-s2.0-68849123857 10.1111/j.1752-699X.2008.00105.x
106. Chapman S. J., Vannberg F. O., Khor C. C., Segal S., Moore C. E., Knox K., Day N. P., Davies R. J. O., Crook D. W., Hill A. V. S., Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease. Molecular Immunology 2007 44 12 3267 3270 2-s2.0-34247281939 10.1016/j.molimm.2006.04.013 (Pubitemid 46610496)
107. Kilpatrick D. C., Mclintock L. A., Allan E. K., Fujita T., Jordanides N. E., Koch C., Matsushita M., Shiraki H., Stewart K., Tsujimura M., Turner M. L., Franklin I. M., Holyoake T. L., No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections. Clinical and Experimental Immunology 2003 134 2 279 284 10.1046/j.1365-2249.2003.02284.x (Pubitemid 37372280)
108. De Messias-Reason I., Kremsner P. G., Kun J. F. J., Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. Journal of Infectious Diseases 2009 199 6 801 804 2-s2.0-65749105631 10.1086/597070
109. Faik I., Oyedeji S. I., Idris Z., de Messias-Reason I. J., Lell B., Kremsner P. G., Kun J. F. J., Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. Human Immunology 2011 72 1 74 79 2-s2.0-78650176476 10.1016/j.humimm.2010.10.003
110. Stengaard-Pedersen K., Thiel S., Gadjeva M., Møller-Kristensen M., Sørensen R., Jensen L. T., Sjöholm A. G., Fugger L., Jensenius J. C., Inherited deficiency of mannan-binding lectin-associated serine protease 2. New England Journal of Medicine 2003 349 6 554 560 2-s2.0-0042709606 10.1056/NEJMoa022836 (Pubitemid 36951367)
111. Schlapbach L. J., Aebi C., Otth M., Leibundgut K., Hirt A., Ammann R. A., Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatric Infectious Disease Journal 2007 26 11 989 994 2-s2.0-37349045286 10.1097/INF.0b013e31811ffe6a (Pubitemid 350287579)
112. Granell M., Urbano-Ispizua A., Suarez B., Rovira M., Fernández- Avilés F., Martínez C., Ortega M., Uriburu C., Gaya A., Roncero J. M., Navarro A., Carreras E., Mensa J., Vives J., Rozman C., Montserrat E., Lozano F., Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Experimental Hematology 2006 34 10 1435 1441 2-s2.0-33748574599 10.1016/j.exphem.2006.06.005 (Pubitemid 44374841)
113. Neth O., Hann I., Turner M. W., Klein N. J., Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. The Lancet 2001 358 9282 614 618 2-s2.0-0035949107 10.1016/S0140-6736(01)05776-2 (Pubitemid 32786825)
114. Summerfield J. A., Clinical potential of mannose-binding lectin-replacement therapy. Biochemical Society Transactions 2003 31 4 770 773 2-s2.0-0041566815 10.1042/BST0310770 (Pubitemid 36981123)
115. Valdimarsson H., Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans. Biochemical Society Transactions 2003 31 4 768 769 2-s2.0-0041566817 10.1042/BST0310768 (Pubitemid 36981122)
116. Valdimarsson H., Vikingsdottir T., Bang P., Saevarsdottir S., Gudjonsson J. E., Oskarsson O., Christiansen M., Blou L., Laursen I., Koch C., Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scandinavian Journal of Immunology 2004 59 1 97 102 2-s2.0-10744223718 10.1111/j.0300-9475.2004.01357.x (Pubitemid 38186845)
117. Petersen K. A., Matthiesen F., Agger T., Kongerslev L., Thiel S., Cornelissen K., Axelsen M., Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. Journal of Clinical Immunology 2006 26 5 465 475 2-s2.0-33748954258 10.1007/s10875-006-9037-z (Pubitemid 44440180)
118. Brouwer N., Frakking F. N. J., Van De Wetering M. D., Van Houdt M., Hart M., Budde I. K., Strengers P. F. W., Laursen I., Houen G., Roos D., Jensenius J. C., Caron H. N., Dolman K. M., Kuijpers T. W., Mannose-Binding Lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels.
119. Frakking F. N. J., Brouwer N., van de Wetering M. D., Budde I. K., Strengers P. F. W., Huitema A. D., Laursen I., Houen G., Caron H. N., Dolman K. M., Kuijpers T. W., Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. European Journal of Cancer 2009 45 4 505 512 2-s2.0-60149092031 10.1016/j.ejca.2008.11.036
120. Hartshorn K. L., Sastry K. N., Chang D., White M. R., Crouch E. C., Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein. American Journal of Physiology 2000 278 1 L90 L98 2-s2.0-0033962409 (Pubitemid 30104179)
121. Stijlemans B., Caljon G., Natesan S. K. A., Saerens D., Conrath K., Pérez-Morga D., Skepper J. N., Nikolaou A., Brys L., Pays E., Magez S., Field M. C., de Baetselier P., Muyldermans S., High affinity nanobodies against the trypanosome brucei VSG are potent trypanolytic agents that block endocytosis. PLoS Pathogens 2011 7 6 2-s2.0-79959851947 10.1371/journal.ppat. 1002072 e1002072
122. Inal J. M., Schneider B., Armanini M., Schifferli J. A., A peptide derived from the parasite receptor, complement C2 receptor inhibitor trispanning, suppresses immune complex-mediated inflammation in mice. Journal of Immunology 2003 170 8 4310 4317 2-s2.0-0037446669 (Pubitemid 36428200)
123. Kulkarni P. A., Afshar-Kharghan V., Anticomplement therapy. Biologics 2008 2 4 671 685
124. Thomas T. C., Rollins S. A., Rother R. P., Giannoni M. A., Hartman S. L., Elliott E. A., Nye S. H., Matis L. A., Squinto S. P., Evans M. J., Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Molecular Immunology 1996 33 17-18 1389 1401 10.1016/S0161-5890(96)00078-8 (Pubitemid 27196373)
125. Spitzer D., Unsinger J., Bessler M., Atkinson J. P., ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement. Molecular Immunology 2004 40 13 911 919 2-s2.0-0346023953 10.1016/j.molimm.2003.10.017 (Pubitemid 38077035)
126. Banz Y., Hess O. M., Robson S. C., Csizmadia E., Mettler D., Meier P., Haeberli A., Shaw S., Smith R. A., Rieben R., Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1. Cardiovascular Research 2007 76 3 482 493 2-s2.0-35548936851 10.1016/j.cardiores.2007.07.016 (Pubitemid 350007457)